We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
To own Maximus, you need to believe that governments will keep leaning on it to run complex health and human services, and that AI-enabled efficiency can offset contract and volume swings. The latest quarter supports that view in the near term: earnings per share rose even as revenue slipped, suggesting margin gains are helping address the key short term catalyst of AI-driven profitability, while the biggest risk around contract volume volatility has not materially changed with this update.
The new US$400 million share repurchase authorization is the most relevant development here. It extends a capital return approach that has already seen Maximus retire about 18.8% of its shares since 2020, which can support earnings per share growth alongside AI-enabled margin improvement. For investors watching how quickly technology gains translate into bottom line progress, this renewed buyback capacity adds another lever while the contract pipeline and budget risks play out.
Yet even as AI helps margins today, investors should be aware that rising automation across government clients could eventually...
Read the full narrative on Maximus (it's free!)
Maximus' narrative projects $5.8 billion revenue and $498.1 million earnings by 2029. This requires 2.8% yearly revenue growth and about a $126.3 million earnings increase from $371.8 million today.
Uncover how Maximus' forecasts yield a $110.00 fair value, a 65% upside to its current price.
Some of the most optimistic analysts were already assuming revenue near US$6.2 billion and earnings around US$512.9 million by 2028, so this margin focused, AI driven quarter may either support that more bullish view or lead you to question it, depending on how you weigh the risk that faster automation adoption could also reduce demand for traditional outsourcing.
Explore 2 other fair value estimates on Maximus - why the stock might be worth over 3x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Opportunities like this don't last. These are today's most promising picks. Check them out now:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English